Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Changes

5 Jul 2017 07:00

RNS Number : 1247K
Cenkos Securities PLC
05 July 2017
 



5 July 2017

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Changes

As reported on 12 May 2017, Jim Durkin, the Company's Chief Executive Officer had informed the Company of his intention to retire from the Company. The Company has since undertaken a search for a successor to Jim Durkin.

Following the completion of this search, Cenkos is pleased to announce that, subject to FCA approval, Anthony Hotson is to be appointed as an Executive Director and to the position of Chief Executive Officer with effect from 1 August 2017. Anthony Hotson has been a Non-Executive Director of the Company since May 2012.

Jim Durkin will resign from the Board and from the position of Chief Executive Officer on 1 August 2017 and will leave the Company on 31 December 2017.

Anthony has extensive experience in financial services having previously worked for the Bank of England, McKinsey & Company and S.G. Warburg. He started his career in the Economics Division of the Bank of England, subsequently moving to the Governors' Office and Money Markets Division. In 1986, he was seconded to the newly-formed Building Societies Commission as Assistant Commissioner. Thereafter, he was employed by McKinsey & Company before joining the corporate finance division of S.G. Warburg. He was a Director of S.G. Warburg & Co. Ltd. from 1992 to 1995 and subsequently Managing Director and Head of the Financial Institutions Group, SBC Warburg (subsequently UBS) until 1998. Following this he served as Non-Executive director in the insurance, fund management and banking sectors, including as a Non-Executive Director of Henderson Group plc where he was a member of the group board and Chairman of its subsidiary companies, London Life and Towry Law. Anthony is Deputy Director of the Centre for Financial History and a senior member of Darwin College, Cambridge.

Gerry Aherne, Chairman said:

"The Board would like to thank Jim for all his hard work and the significant contribution that he has made to the development of the business and he will leave with our best wishes."

"I have every confidence in Anthony in leading the Company going forward as the Company's new Chief Executive Officer. Anthony is exceptionally well placed to undertake the role and his wealth of experience will be a valuable asset for the Company in his new executive role. Having been a director of the Company since May 2012, Anthony has previously been involved in reviewing the firm's structure, governance and processes, including the impact that changing regulations may have, and he has been actively involved with the management of the Company in this respect. "

 

Enquiries:

 

Jim Durkin +44 20 7397 8900

Chief Executive Officer

Cenkos Securities plc

 

Dr Azhic Basirov / David Jones / Ben Jeynes +44 20 7131 4000

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

David Rydell / Duncan Mayall +44 20 3772 2496

Bell Pottinger

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLGDRUSGBGRS
Date   Source Headline
13th May 202012:43 pmRNSBoard Update
13th May 20208:41 amRNSForm 8.5 (EPT/NON-RI)
12th May 20208:38 amRNSForm 8.5 (EPT/NON-RI)
11th May 20205:29 pmRNSPDMR Dealings
11th May 20205:21 pmRNSTR-1: Notification of major holdings
11th May 202010:29 amRNSForm 8.5 (EPT/NON-RI)
7th May 20206:06 pmRNSPDMR Shareholding
7th May 20206:06 pmRNSPDMR Shareholding
7th May 20208:51 amRNSForm 8.5 (EPT/NON-RI)
6th May 20208:47 amRNSForm 8.5 (EPT/NON-RI)
5th May 20208:27 amRNSForm 8.5 (EPT/NON-RI)
4th May 20208:50 amRNSForm 8.5 (EPT/NON-RI)
4th May 20208:49 amRNSForm 8.5 (EPT/NON-RI)
1st May 202012:12 pmRNSDirector Shareholding
1st May 20209:02 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20205:26 pmRNSDirector Shareholding
30th Apr 20205:24 pmRNSPDMR Shareholding
30th Apr 20208:26 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20207:00 amRNSAnnual Results for the year ended 31 December 2019
29th Apr 20208:28 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 20208:25 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20203:06 pmRNSBoard Update
28th Apr 20209:16 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 20208:33 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20209:40 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20209:38 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 20209:59 amRNSEBT Share Purchase
23rd Apr 20209:09 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 202010:33 amRNSEBT Share Purchase
22nd Apr 20209:29 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:34 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:21 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:18 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20203:14 pmRNSBlock Admission Interim Review
17th Apr 20208:35 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20208:32 amRNSForm 8.5 (EPT/NON-RI)
14th Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
9th Apr 20209:30 amRNSForm 8.5 (EPT/NON-RI)
8th Apr 202011:36 amRNSForm 8.5 (EPT/NON-RI)
7th Apr 20208:41 amRNSForm 8.5 (EPT/NON-RI)
6th Apr 20208:33 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 202010:16 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 20207:00 amRNSDeferral of publication of results and COVID 19
2nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
1st Apr 20209:55 amRNSForm 8.5 (EPT/NON-RI)
30th Mar 20209:08 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 20207:41 amRNSForm 8.5 (EPT/NON-RI)
26th Mar 20209:59 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.